论文信息 - Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: a retrospective cohort study - 字舞流文

Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: a retrospective cohort study

D. Chudakov | I. Strazhesko | Z. Mutovina | A. Zagrebneva | A. Akopyan | V. Skatova | T. S. Kruglova | A. BryushkovaE. | Sergey A. Lukyanov | Daria S. Fomina | Maryana A. Lysenko | Ekaterina A Bryushkova | O. Tkacheva